Drug
Aav5 Hfixco Padua
Aav5 Hfixco Padua: highest development phase Phase 3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| AAV5-hFIXco-Padua NCT03569891 | Phase 3 | Hemophilia B |
Latest
No recent events.
Follow Aav5 Hfixco Padua on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.